Northwire Canada EditionThursday, July 30, 2026
Sign inSubscribe
Northwire
⌕
FCI 0.330 +0.0% SGQ 0.350 +0.0% TECK 85.57 +5.8% BIG 0.750 +27.1% PTU 0.320 −3.0% GZD 0.080 −11.1% AFM 1.45 +1.4% VCT 0.065 +8.3% BEM 0.060 −7.7% NMI 0.195 +0.0% VLD 0.540 +0.0% BOL 0.080 +6.7% EDCU 0.430 −2.3% SYH 0.380 +2.7% TECT 2.10 +2.4% NAU 1.49 −0.7% FCI 0.330 +0.0% SGQ 0.350 +0.0% TECK 85.57 +5.8% BIG 0.750 +27.1% PTU 0.320 −3.0% GZD 0.080 −11.1% AFM 1.45 +1.4% VCT 0.065 +8.3% BEM 0.060 −7.7% NMI 0.195 +0.0% VLD 0.540 +0.0% BOL 0.080 +6.7% EDCU 0.430 −2.3% SYH 0.380 +2.7% TECT 2.10 +2.4% NAU 1.49 −0.7%
M&A / Property

Biosenta to Field-Test Antimicrobial Nanoparticles with Livespace Homes in Alberta Multi-Unit Build

By The Northwire Desk — AI Analysis Dec 11, 2025 · 14:22 ZRO · 0.1 BIOSENTA Inc.
ZRO · Price

Executive Summary

  • Biosenta Inc. entered into a Field Test and Research Agreement with Livespace Homes to evaluate its proprietary antimicrobial nanoparticle technology in two residential units of a four‑plex project.
  • The field test will generate real‑world performance, durability, and efficacy data to support commercialization planning, partner discussions, and scaling opportunities.
  • Company leadership highlighted the potential for the technology to improve indoor health by protecting surfaces from bacteria and mold.

Key Details

  • Agreement Date: December 8 2025.
  • Parties: Biosenta Inc. (CSE: ZRO) and Livespace Homes.
  • Scope of Test: Incorporation of Biosenta’s antimicrobial nanoparticles into building materials/coatings in 2 of the 4 units of a Livespace four‑plex residential project for side‑by‑side performance comparison.
  • Objectives:
  • Validate laboratory results in a real residential environment.
  • Collect structured observations on efficacy, durability, and commercial viability.
  • Inform product development, partner engagement, and market adoption strategies.
  • Technology: Proprietary antimicrobial nanoparticle that provides durable protection against bacteria, molds, and fungi when embedded in interior surfaces and materials.
  • Quotes:
  • “People want homes that feel clean and safe… our technology is designed to help protect surfaces from bacteria and mold…” – Am Gill, President & CEO, Biosenta.
  • “This is a first‑of‑its‑kind field test in a live multi‑unit build…” – Gurpreet Gill, President, Livespace Homes.

Notable Quotes

  • Am Gill (President & CEO, Biosenta): “Our technology is designed to help protect surfaces from bacteria and mold, so families can worry less about what they cannot see.”
  • Gurpreet Gill (President, Livespace Homes): “We’re always looking for practical innovations that can improve the performance and livability of the spaces we build… this field test will allow us to evaluate Biosenta’s antimicrobial nanotechnology in real conditions.”
Read the original news release →

More from BIOSENTA Inc.

Dec 11, 2025 · 19:19

Biosenta, Livespace Homes enter field test deal

M&A / Property